Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,009.50    -16.50 (-1.61%)
Bid:
1,014.50
Ask:
1,015.50
Spread: 1.00 (0.099%)
Market Cap: £4.97b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Final Terms

10 Jul 2026 17:35

RNS Number : 9659L
Babcock International Group PLC
10 July 2026
 

 

 

10 July 2026

Babcock International Group PLC

 

BABCOCK INTERNATIONAL GROUP PLC £250 million BOND ISSUE

Babcock International Group ('the Group' or 'Babcock') announces the issue of £250 million of five-year bonds carrying fixed coupon of 5.125%, the Group's first bond issue for seven years, to refinance the £300 million bond maturing in October 2026.

 

Babcock's strong proposition, fundamentals and balance sheet, combined with leading market positioning in defence and nuclear, has led to a high level of demand, allowing us to price on attractive terms.

 

The net proceeds of the issue will be used for general corporate purposes, including ongoing investment to support and drive growth.

 

BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS

The final terms dated 10 July 2026 (the "Final Terms") relating to the issue by Babcock on 14 July 2026 of GBP 250,000,000 5.125% per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.

The Notes have been issued pursuant to the base prospectus dated 3 March 2026 (the "Base Prospectus") relating to the £3,000,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/9659L_1-2026-7-10.pdf

A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

 

Andrew Gollan

Samuel MacGregor

Director of Investor Relations

Investor Relations Manager

Tel: (0)7936 039004

Tel: (0)7730 753159

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTRMMFTMTJBBBF
Date   Source Headline
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report
6th Nov 20154:00 pmRNSHolding(s) in Company
23rd Oct 201511:17 amRNSHolding(s) in Company
19th Oct 20152:17 pmRNSDirectorate Change
12th Oct 201510:00 amRNSDefence & Security Division: Contract Update
23rd Sep 20158:00 amRNSDirectorate Changes
18th Sep 20154:59 pmRNSPublication of Base Prospectus
17th Aug 20159:20 amRNSDirector/PDMR Shareholding
3rd Aug 201510:30 amRNSHolding(s) in Company
31st Jul 201511:31 amRNSDirector/PDMR Shareholding
31st Jul 201510:04 amRNSDirector/PDMR Shareholding
30th Jul 20154:24 pmRNSResult of AGM
30th Jul 20158:57 amRNSHolding(s) in Company
30th Jul 20157:00 amRNSAnnual General Meeting Trading Update
17th Jul 201511:29 amRNSDirector/PDMR Shareholding
14th Jul 20153:07 pmRNSHolding(s) in Company
10th Jul 201511:50 amRNSHolding(s) in Company
17th Jun 20154:58 pmRNSAnnual Financial Report
17th Jun 20154:38 pmRNSDirector/PDMR Shareholding
12th Jun 20153:25 pmRNSHolding(s) in Company
12th Jun 201510:06 amRNSDirector/PDMR Shareholding
10th Jun 20159:36 amRNSHolding(s) in Company
3rd Jun 20152:59 pmRNSHolding(s) in Company
3rd Jun 201510:23 amRNSTotal Voting Rights
1st Jun 20153:32 pmRNSNew Listing
18th May 201511:11 amRNSEurope midday: Stocks waver in a tight range; eyes still on Greece
18th May 20157:00 amRNSFinal Results
1st Apr 20154:48 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSCapital markets seminar and trading update
3rd Mar 201510:30 amRNSAppointment of non executive director
10th Feb 20157:00 amRNSInterim Management Statement
30th Jan 201510:42 amRNSDirector/PDMR Shareholding
20th Jan 201510:00 amRNSCavendish Nuclear contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.